PhRMA PRESIDENT-ELECT IS ALAN HOLMER: D.C. ATTORNEY BRINGS INTERNATIONAL TRADE BACKGROUND, EXPERIENCE IN GOP LEGISLATIVE & EXECUTIVE BRANCHES TO ASSOCIATION
Alan Holmer will succeed Gerald Mossinghoff as president of the Pharmaceutical Research & Manufacturers of America July 15, the association announced April 17 following its annual meeting in New York City. Holmer, 46, currently heads the international trade practice in the Washington office of Sidley & Austin. He has been trade counsel to PhRMA for the past six years. While he has not had a high profile at the association, his connection should make it easier for him to move into the top job.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth